Integrating novel BCMA-directed therapies into clinical practice: Insights from real-world experience
Agenda
This program has been accredited for one hour of CME credit.
BCMA-directed therapies in multiple myeloma: Current applications and the evolving clinical landscape
Panel discussion | Practical considerations when sequencing novel agents and managing adverse events with BCMA-directed therapies
Future directions with novel and established BCMA-directed therapies in the multiple myeloma treatment paradigm
Following the close of the symposium, there will be an optional 'Virtual exhibitor space' session with the symposium speakers and GSK representatives as an opportunity for further discussion and networking.
Learning objectives
Following the symposium, learners will be able to:
- Describe the mechanisms of action of different BCMA-directed therapies for the treatment of multiple myeloma.
- Recall key clinical trials and real-world evidence supporting the use of BCMA-directed therapies in multiple myeloma.
- Recall key considerations for patient selection, eligibility, and sequencing of BCMA-directed therapies.
- Describe strategies to overcome mechanisms of resistance to BCMA-directed therapies, including options for retreatment.
- Describe strategies to manage common toxicities associated with BCMA-directed therapies and optimize patient quality of life.
Our speakers
Meet our panel of experts
Hermann Einsele
Julius-Maximilians-Universität Würzburg
Würzburg, DE
Marc-Andrea Bärtsch
Heidelberg University and German Cancer Research Center (DKFZ)
Heidelberg, DE
Gordon Cook
University of Leeds
Leeds, UK
María-Victoria Mateos
University Hospital of Salamanca
Salamanca, ES
About SES
Delivering streamlined independent medical education to enhance clinical practice. SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide with up-to-date, accessible, and impactful educational content.
About the Multiple Myeloma Hub
The Multiple Myeloma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in multiple myeloma. Our aim is to enhance knowledge in multiple myeloma, through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.
The Multiple Myeloma Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage with treatment teams and researchers around the world.